skip to main content
primary care & preventionformula

SCORE2 (ESC 10-year CVD Risk)

iatroX editorial team · Updated · Record checked · editorial policy

SCORE2 estimates 10-year risk of fatal and non-fatal cardiovascular events for European adults aged 40–69 without prior CVD or diabetes. SCORE2-OP extends to ages 70–89. It replaces the original SCORE (fatal CVD only) with region-specific calibration across four European risk regions.

calculate with the official tool

Use the official calculator for this model, then return here for interpretation and related guidance.

Open ESC HeartScore ↗
evidence

derivation

Developed by the SCORE2 Working Group (Eur Heart J 2021) from pooled data of 677,684 individuals across 45 European cohorts. Uses age, sex, smoking, systolic BP, and non-HDL cholesterol.

validation

Validated in 1,133,181 individuals. Calibrated to four European risk regions based on country-level CVD mortality rates. Well calibrated across the age spectrum.

guideline endorsements

ESC 2021 uses age-dependent categories. Under 50 years: high risk 2.5% to below 7.5%, very high risk 7.5% or more. At 50–69: high risk 5% to below 10%, very high risk 10% or more. Use SCORE2-OP from 70 years.

regional interpretation
EU: SCORE2 is the ESC-recommended tool. Use heartscore.org with appropriate country selection.
UK: Use QRISK3 instead (NICE-recommended).
US: Use ASCVD Pooled Cohort Equations instead (ACC/AHA-recommended).
references
  1. SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439-2454.PMID: 34120177
  2. Visseren FLJ, Mach F, Smulders R, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337.PMID: 34458905
  3. Supporting guidance — doi.org (checked 14 November 2026).link ↗